Status:
COMPLETED
Scaling Mental Healthcare in COVID-19 With Voice Biomarkers
Lead Sponsor:
Kintsugi Mindful Wellness, Inc.
Conditions:
Major Depressive Disorder
Generalized Anxiety
Eligibility:
All Genders
18-100 years
Brief Summary
This study aims to advance research on group sessions for mental health. The first-of-its-kind study measuring various features in a group setting, combining rich metadata in creating state-of-the-art...
Detailed Description
The anticipated impact of this study is defining voice biomarker features and reward functions for a deep reinforcement learning based system from group interactions that improve depression and anxiet...
Eligibility Criteria
Inclusion
- Ownership of a personal iPhone (version iOS 12.0 or later) and willingness to install and maintain the Kintsugi app for remote participation throughout the study duration
- Able to understand and comply with instructions in English
Exclusion
- Has any other clinically significant medical condition or circumstance that, in the opinion of the Investigator, could affect patient safety, preclude evaluation of response, interfere with the ability to comply with study procedures, or prohibit completion of the study
- Has a visual or physical motor impairment that could interfere with study tasks
- Is site personnel directly affiliated with this study
Key Trial Info
Start Date :
January 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04510519
Start Date
January 12 2022
End Date
March 2 2022
Last Update
September 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kintsugi Mindful Wellness, Inc.
Berkeley, California, United States, 94705